ACTINIUM PHARMACEUTICALS, INC. (ATNM) Total liabilities 2010–2025
ACTINIUM PHARMACEUTICALS, INC. (ATNM) total liabilities at each fiscal year-end, per SEC filings.
$43.9MFY2025 · since FY2010: $94,768 → $43.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $43.9M | — |
| FY2023 | $45.1M | -5.5% |
| FY2022 | $47.7M | +597.2% |
| FY2021 | $6.8M | — |
| FY2011 | $84,479 | -10.9% |
| FY2010 | $94,768 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice